Study on the Association Between Vitamin C Deficiency and Diarrhea in Children

NCT ID: NCT05328037

Last Updated: 2026-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

288 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-25

Study Completion Date

2024-03-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diarrheal disease is the second leading cause of death in children under five, althought it is both preventable and treatable. The causative factors of diarrheal diseases vary a lot from region to region (bacteria, viruses, parasites). Diarrhea is one of the main causes of malnutrition in children under five years of age. Inversely, nutritional deficiency, particularly vitamin C deficiency, can be a risk factor for diarrhea.

The main objective of this study is to assess the impact of vitamin C deficiency on diarrheal infection in children aged 2 to 5 years in countries with a high diarrheal rate. This pilot case-control study will be conducted in metropolitan France, Africa and South America. This question will be addressed by comparing vitamin C levels in children with diarrhea, regardless of the infectious agent, to levels in age- and sex-matched controls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diarrheal disease is the second leading cause of death in children under five, althought it is both preventable and treatable. The causative factors of diarrheal diseases vary a lot from region to region (bacteria, viruses, parasites). Diarrhea is one of the main causes of malnutrition in children under five years of age. Inversely, nutritional deficiency, particularly vitamin C deficiency, can be a risk factor for diarrhea.

The main objective of this study is to assess the impact of vitamin C deficiency on diarrheal infection in children aged 2 to 5 years in countries with a high diarrheal rate. This pilot case-control study will be conducted in metropolitan France, Africa and South America. This question will be addressed by comparing vitamin C levels in children with diarrhea, regardless of the infectious agent, to levels in age- and sex-matched controls.

The study aims at (i) determining whether vitamin-deficiency may occurs in children living in developing countries and at (ii) determining the plasma vitamin A, C and E concentrations in children suffering of diarrheal diseases.

A total of 360 children will participate to the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diarrhea Infantile

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute diarrhea cases

Children with acute diarrhea defined as at least 3 loose or watery stools per day for at least 3 consecutive days and up to 10 consecutive days

Blood sample collection

Intervention Type DIAGNOSTIC_TEST

Blood sample collection for dosage of vitamin C

Chronic diarrhea cases

Children with chronic diarrhea defined as 3 or more loose or liquid stools per day for at least 4 weeks

Blood sample collection

Intervention Type DIAGNOSTIC_TEST

Blood sample collection for dosage of vitamin C

Controls

Children without fever or signs of infection or ongoing diarrhea

Blood sample collection

Intervention Type DIAGNOSTIC_TEST

Blood sample collection for dosage of vitamin C

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood sample collection

Blood sample collection for dosage of vitamin C

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* not suffering of diarrhea
* no fever
* no sign of infection


-Children suffering from chronic diarrhea defined by the emission of at least 3 soft or liquid stools per day for at least 4 weeks.


-Children suffering from acute diarrhea defined as 3 or more loose or watery stools per day for at least 3 consecutive days and up to 10 consecutive days.

Exclusion Criteria

* Suspected or diagnosed infectious diseases
* Known genetic diseases
* Known diseases that may interfere with iron and/or vitamin C metabolism
* Known inflammatory diseases
* Malnutrition
* Diarrhea
* Fever
* Positive malaria rapid diagnostic test (Africa)
* Child currently being breastfed

Chronic diarrhea cases :


* Suspected or diagnosed infectious diseases
* Known genetic diseases
* Known diseases that may interfere with iron and/or vitamin C metabolism
* Known inflammatory diseases
* Positive malaria rapid diagnostic test (Africa)
* Antibiotic treatment prescribed within 10 days prior to sampling
* Nutritional supplements in the three months prior to sampling
* Vitamin C supplementation in the last 3 months prior to blood collection
* Child currently being breastfed

Acute diarrhea cases :


* Malnutrition
* Suspected or diagnosed infectious diseases
* Known genetic diseases
* Known diseases that may interfere with iron and/or vitamin C metabolism
* Known inflammatory diseases
* Positive malaria rapid diagnostic test (Africa)
* Antibiotic treatment prescribed within 10 days prior to sampling
* Nutritional supplements in the three months prior to sampling
* Vitamin C supplementation in the last 3 months prior to blood collection
* Child currently being breastfed
Minimum Eligible Age

18 Months

Maximum Eligible Age

60 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Cochin

OTHER

Sponsor Role collaborator

University of Copenhagen

OTHER

Sponsor Role collaborator

Institut Pasteur

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexandre Manirakiza, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Institut Pasteur de Bangui, Centrafrican Republic

Thomas Blanc, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hopital Necker Paris, France

Jean-Chrysostome Gody, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Complexe Pédiatrique de Bangui, Centrafrican Republic

Emilie Huguon, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Térritorial Gaston Bourret, New Caledonia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Complexe Pédiatrique

Bangui, , Central African Republic

Site Status

Hopital Necker

Paris, , France

Site Status

Centre Hospitalier Territorial Gaston Bourret

Noumea, , New Caledonia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Central African Republic France New Caledonia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ID-RCB number : 2021-A00632-39

Identifier Type: OTHER

Identifier Source: secondary_id

2020-063

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VCSIP Follow-up Study
NCT03203603 COMPLETED
The Motility Mother-Child Cohort
NCT05491161 ACTIVE_NOT_RECRUITING
Vitamin B12, Neurodevelopment and Growth in Nepal
NCT02272842 UNKNOWN PHASE2/PHASE3